We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » ICER Names Seven Drugs That Saw Unjustified Price Hikes in 2019
ICER Names Seven Drugs That Saw Unjustified Price Hikes in 2019
The Institute for Clinical and Economic Review (ICER) points out seven high-cost treatments whose prices were raised in 2019 without supportive clinical data and cost the U.S. health system $1.2 billion in annual drug spending, in a new analysis released Tuesday.